Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Found 15084 publications
PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023 US$ 10,995.00

... strategies by understanding the trends shaping and driving the global asthma therapeutics market. Drive revenues by understanding the key trends, innovative ... effective counter-strategies to gain a competitive advantage. Track drug sales in the global asthma therapeutics market from 2013-2023. Organize your ...

Aug, 2014 383 pages
2014 Market Research Report on Global Insulin Industry US$ 2,200.00

2014 Market Research Report on Global Insulin Industry is a professional and depth research report on Global Insulin industry. For overview analysis, the ... also covers upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals. In the end, the ...

Nov, 2014 139 pages
Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2014 US$ 2,000.00

... , H2 2014’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Nov, 2014 304 pages
Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2014 US$ 2,000.00

... , H2 2014’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Nov, 2014 302 pages
Idiopathic Juvenile Arthritis (Still's Disease) - Pipeline Review, H2 2014 US$ 2,000.00

... Arthritis (Still's Disease) - Pipeline Review, H2 2014’, provides an overview of the Idiopathic Juvenile Arthritis (Still's Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Idiopathic Juvenile Arthritis (Still's Disease), complete with ...

Nov, 2014 70 pages
Physician Views: Will next-generation long-acting insulins prove compelling? US$ 645.00

... also increased in light of Sanofi's recent disclosure that Lantus sales will be flat next year (due most likely to greater rebating with payers) ... this Physician Views poll. Specifically we are asking US and EU5-based endocrinologists... Based on your knowledge of clinical data for newer long-acting insulins ...

Nov, 2014
Women Infertility Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... and data relating to the clinical trials on Women Infertility. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Nov, 2014 118 pages
Male Infertility Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... and data relating to the clinical trials on Male Infertility. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Nov, 2014 80 pages
Dermatophytosis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Summary GlobalData's clinical trial report, “Dermatophytosis Global Clinical Trials Review, H2, 2014' provides data on the Dermatophytosis clinical trial scenario. This ... and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / ...

Nov, 2014 83 pages
Cryptosporidiosis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... 2014 Summary GlobalData's clinical trial report, “Cryptosporidiosis Global Clinical Trials Review, H2, 2014' provides data on the Cryptosporidiosis clinical trial scenario. This ... America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each ...

Nov, 2014 54 pages
Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... and data relating to the clinical trials on Cryptococcal Meningitis. It includes an overview of the trial numbers and their recruitment status as per the ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Nov, 2014 76 pages
Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Review, H2, 2014' provides data on the Chagas Disease (American Trypanosomiasis) clinical trial scenario. This report provides elemental information and data ... and top five national contributions in each Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor ...

Nov, 2014 63 pages
Cerebral (Fatal) Malaria Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Review, H2, 2014' provides data on the Cerebral (Fatal) Malaria clinical trial scenario. This report provides elemental information and data relating ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Nov, 2014 60 pages
Bacterial Vaginosis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... and data relating to the clinical trials on Bacterial Vaginosis. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Nov, 2014 77 pages
Bacterial Sepsis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... and data relating to the clinical trials on Bacterial Sepsis. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Nov, 2014 62 pages
Bacterial Pneumonia Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... and data relating to the clinical trials on Bacterial Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Nov, 2014 142 pages
Aspergillosis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... 2014 Summary GlobalData's clinical trial report, “Aspergillosis Global Clinical Trials Review, H2, 2014' provides data on the Aspergillosis clinical trial scenario. This ... and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities ...

Nov, 2014 124 pages
Anthrax Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Summary GlobalData's clinical trial report, “Anthrax Global Clinical Trials Review, H2, 2014' provides data on the Anthrax clinical trial scenario. This ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Nov, 2014 77 pages
African Trypanosomiasis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... and data relating to the clinical trials on African Trypanosomiasis. It includes an overview of the trial numbers and their recruitment status as per the ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Nov, 2014 46 pages
2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,200.00

This unique report from Venture Planning Group provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 122 pages
2014-2018 UK Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,000.00

This unique report from Venture Planning Group provides UK sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 121 pages
2014-2018 Spain Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,000.00

This unique report from Venture Planning Group provides Spain sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 121 pages
2014-2018 Japan Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,000.00

This unique report from Venture Planning Group provides Japan sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 121 pages
2014-2018 Italy Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,000.00

This unique report from Venture Planning Group provides Italy sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 121 pages
2014-2018 Germany Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,000.00

This unique report from Venture Planning Group provides Germany sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 121 pages
2014-2018 France Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,000.00

This unique report from Venture Planning Group provides France sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 121 pages
2014-2018 European Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 4,200.00

This unique report from Venture Planning Group provides Europe sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing ...

Nov, 2014 129 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 4,850.00

This unique report from Venture Planning Group provides sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 134 pages
2014-2018 UK Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer, Forensic... US$ 6,700.00

... of automated and semiautomated analyzers. Sales and market shares of leading suppliers. Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, ...

Nov, 2014 855 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 32,200.00

... major suppliers of molecular diagnostic reagent kits and components. Five-year test volume and sales forecasts for major applications, including: Infectious ... HLA Typing Genetic Diseases Others Five-year test volume and sales projections for over 30 NAT assays. A comprehensive analysis of the sequencing ...

Nov, 2014 1050 pages
2014-2018 Spanish Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 6,700.00

This report presents a comprehensive analysis of the Spanish molecular diagnostics market, including: issues pertaining to the Spanish molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ...

Nov, 2014 850 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants US$ 2,500.00

The report presents insightful analyses of major current and emerging suppliers of molecular diagnostic products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 120 pages

Nov, 2014 120 pages
2014-2018 Japanese Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 8,500.00

This new 860-page report from Venture Planning Group contains 36 tables, and presents a comprehensive analysis of the Japanese molecular diagnostics market, including: issues pertaining to the Japanese molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and ...

Nov, 2014 860 pages
2014-2018 Italian Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 6,700.00

This report presents a comprehensive analysis of the Italian molecular diagnostics market, including: issues pertaining to the Italian molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ...

Nov, 2014 850 pages
2014-2018 German Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 6,700.00

This report presents a comprehensive analysis of the German molecular diagnostics market, including: issues pertaining to the German molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten ...

Nov, 2014 850 pages
2014-2018 French Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 6,700.00

This report presents a comprehensive analysis of the French molecular diagnostics market, including: issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten ...

Nov, 2014 850 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Facilities, Test Volumes, and Sales Forecasts by Country US$ 2,450.00

... provides: Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA Estimates of facilities performing DNA sequencing and molecular diagnostic testing by country. Five-year test volume and sales forecasts by country. Contains 15 pages and 4 tables

Nov, 2014 15 pages
2014-2018 US Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer, Forensic... US$ 9,500.00

... of automated and semiautomated analyzers. Sales and market shares of leading suppliers. Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, ...

Nov, 2014 880 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Emerging Technologies and Strategic Profiles of Leading Suppliers US$ 3,500.00

This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other. The report also presents ...

Nov, 2014 180 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Latest Instrumentation and Strategic Profiles of Leading Suppliers US$ 3,500.00

This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating molecular diagnostics methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e.g., DNA ...

Nov, 2014 103 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers US$ 3,500.00

... provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and sales forecasts by country. The report also presents strategic profiles of current and emerging suppliers of molecular ...

Nov, 2014 109 pages
2014-2018 European Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 19,700.00

... entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The ... business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares ...

Nov, 2014 970 pages
2014-2018 US Drugs of Abuse Decentralized/POC Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers - Supplier Shares, Sales Forecasts, Emerging Technologies,... US$ 2,500.00

... Group contains 14 tables, and provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory ... . Five-year test volume and reagent sales forecasts for drugs of abuse procedures by market segment: Physician Offices/Group Practices Emergency ...

Nov, 2014 165 pages
2015 U.S. Drugs, health aids, beauty aids sold through Supermarkets & other grocery (except convenience) stores-Product & Retail Report US$ 199.00

The 2015 U.S. Drugs, health aids, beauty aids sold through Supermarkets & other grocery (except convenience) stores-Product & Retail Report, published ... on the sales of Drugs, health aids, beauty aids sold through Supermarkets & other grocery (except convenience) stores nationally and for all 50 U.S. States and ...

Nov, 2014 96 pages
2015 U.S. Drugs, health aids, beauty aids sold through Pharmacies & drug stores-Product & Retail Report US$ 199.00

The 2015 U.S. Drugs, health aids, beauty aids sold through Pharmacies & drug stores-Product & Retail Report, published annually by Barnes Reports, contains ... estimates on the sales of Drugs, health aids, beauty aids sold through Pharmacies & drug stores nationally and for all 50 U.S. States and up to 900 metro ...

Nov, 2014 96 pages
2015 U.S. Drugs, health aids, beauty aids sold through Gasoline stations with convenience stores-Product & Retail Report US$ 199.00

The 2015 U.S. Drugs, health aids, beauty aids sold through Gasoline stations with convenience stores-Product & Retail Report, published annually by Barnes ... on the sales of Drugs, health aids, beauty aids sold through Gasoline stations with convenience stores nationally and for all 50 U.S. States and up to 900 ...

Nov, 2014 96 pages
2015 U.S. Drugs, health aids, beauty aids sold through Beer, wine, & liquor stores-Product & Retail Report US$ 199.00

The 2015 U.S. Drugs, health aids, beauty aids sold through Beer, wine, & liquor stores-Product & Retail Report, published annually by Barnes Reports, ... 2016 forecast estimates on the sales of Drugs, health aids, beauty aids sold through Beer, wine, & liquor stores nationally and for all 50 U.S. States and up to ...

Nov, 2014 94 pages
Clinical Trials US$ 1,000.00

... Management Consultancy S.A. and aims to reflect the current state of the Clinical Trials in Greece and to examine its prospects, while presenting information ... research The Greek businesses of the sector usually take over clinical studies from multinational pharmaceutical companies or are sub-contracting from ...

Sep, 2014
Vitamins China E-News 1410 US$ 3,564.00

... vitamin market. Affected by the increasing demand of overseas market, China’s VC export volume rises by 12% year on year in Jan.-Aug. 2014. And VE increases by 20%. As for ... of concern for the domestic vitamin industry. As the largest VD3 manufacturer in China, Garden Bio-chemical benefits from the price rise ...

Oct, 2014 33 pages
Vitamin Trade Flows in China/industry publications US$ 2,160.00

... a direct analyse of China's vitamin trade flows around the volume, price, partners, and an indirect description of industry changes. What to report: In this report, import and export of China's vitamins in 2013 and H1 2014 are analyzed in the following aspects: Trade volume and value of ...

Oct, 2014 58 pages
1 2 3 4 5 >
Skip to top